KVUE · News · 20260804N
Revenue Performance and Mix
Kenvue Inc. · 2026-08-04 · Importance 31 · Surprise 32 · No source text
Kenvue’s second-quarter 2026 net sales increased 3.0% year over year to $3.955 billion, compared with an analyst estimate of approximately $3.97 billion to $3.99 billion. Growth was broad-based across the Self Care, Skin Health and Beauty, and Essential Health segments. Net and organic sales increased for the third consecutive quarter across all regions, while volume growth reached 0.7%. Muted performance in the United States and Europe was offset by growth elsewhere and continued product demand for brands including Tylenol, Neutrogena, and Listerine.
Key facts
- Kenvue exceeded Q1 earnings expectations with adjusted EPS of $0.32 and revenue of $3.91 billion, a 4.5% year-over-year increase. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +4.3% | Kenvue exceeded Q1 earnings expectations with adjusted EPS of $0.32 and revenue of $3.91 billion, a 4.5% year-over-year increase. |